Description
Delta sleep-inducing peptide is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1977 from the cerebral venous blood of rabbits in which slow-wave sleep had been induced by thalamic stimulation. It was named for its reported ability to promote delta-wave EEG activity in recipient animals.
Since then, DSIP has been investigated in animal models for effects on sleep architecture, circadian patterns, stress-hormone release and thermoregulation. Despite decades of research, no specific DSIP receptor or gene has been identified, and its physiological role remains a subject of debate, which keeps it of interest to neuroendocrine researchers. Analogues with modified residues have also been synthesised to probe which parts of the sequence matter for activity.
Store the lyophilised peptide sealed and frozen.
For use by qualified researchers in a laboratory setting only. Not intended for human or veterinary use of any kind.
Supplied as a 10-vial kit of lyophilised powder. Dispatched in 1–2 business days.




